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iABSTRACT
The interaction between genes and the environment such as mineral and trace elements 
are now regarded as the most probable explanation of autism (Yasuda, Yoshida, Yasuda, & 
Tsutsui, 2013). Weismer, Lord, and Esler (2010) identified children associated with pervasive 
developmental disorder not otherwise specified (PDD-NOS) and autism have exhibited 
substantial language delays compared to children of their chronological age. Language delays
were found to profoundly impact both receptive and expressive language. The participant in this 
study was a three year-old female who was previously diagnosed with Autism Spectrum 
Disorder (ASD). For the experiment, the child was administered articulation and language 
standard evaluations in order to create expressive language goals. The participant’s clinician 
created language goals and skilled speech therapy initiated. The participant was administered a 
50mg zinc supplement nine weeks into therapy to measure the effects of this trace element on
expressive language. The results were inconclusive in that the participant exhibited improved 
language abilities with and without zinc.  Continuous research is warranted to gain better 
understanding of the effects of zinc supplementation on expressive language in children 
associated with ASD.  
  ii 
Table of Contents
INTRODUCTION .......................................................................................................................... 1
REVIEW OF THE LITERATURE ................................................................................................ 5
PERVASIVE DEVELOPMENTAL DISORDERS ................................................................................... 5
ROLE OF ZIN................................................................................................................................. 7
ZINC SUPPLEMENTATION RELATED TO TREATMENT .................................................................. 11
LANGUAGE DEFICITS ................................................................................................................. 11
METHODS ................................................................................................................................... 15
PARTICIPANTS ............................................................................................................................ 15
PROCEDURES.............................................................................................................................. 15
Initial speech and language evaluation. ................................................................................. 15
Measurement of zinc and copper levels. ............................................................................... 16
Administration of zinc supplement........................................................................................ 17
Collection of data during therapy. ......................................................................................... 18
ANALYSIS................................................................................................................................... 19
RESULTS ..................................................................................................................................... 20
SUMMARY OF EXPRESSIVE LANGUAGE FUNCTION WITHOUT ZINC SUPPLEMENTATION ............. 20
HEAVY METAL TEST RESULTS................................................................................................... 21
DISCUSSION............................................................................................................................... 27
LIMITATIONS AND RECOMMENDATIONS..................................................................................... 29
CONCLUSIONS ............................................................................................................................ 30
REFERENCES ............................................................................................................................. 31
APPENDIX A............................................................................................................................... 35
APPENDIX B ............................................................................................................................... 39
  iii 
LIST OF TABLES
Table 1. Clinical data and percent change during the nine sessions of therapy without 
zinc supplementation and six sessions of therapy with zinc supplementation 
for Goal 1 (imitatively produce the phoneme /p/ in isolation when provided 
when provided with visual cues)………………………………………………………22
Table 2.  Clinical data and percent change during the nine sessions of therapy without 
zinc supplementation and six sessions of therapy with zinc supplementation 
for Goal 2 (correctly using progressive verbs presented on picture cards)…………...23
Table 3.  Clinical data and percent change during the nine sessions of therapy without 
zinc supplementation and six sessions of therapy with zinc supplementation 
for Goal 3 (correctly using emotion words presented on picture cards)……………..24
Table 4.  Clinical data and percent change during the nine sessions of therapy without 
zinc supplementation and six sessions of therapy with zinc supplementation 
for Goal 4 (correctly sequence events using a simple, three-step sequence 
provided on picture cards)……………………………………………………………25
Table 5.  Clinical data and percent change during the nine sessions of therapy without 
zinc supplementation and six sessions of therapy with zinc supplementation 
for Goal 5 (spontaneously produce three- to four-word utterances during play-
based and structured therapy tasks)…………………………………………………...26
  iv 
ACKNOWLEDGEMENTS
I would like to express my sincerest gratitude to my thesis chair, Dr. Mary Gorham-Rowan for 
her constant support, unyielding optimism, and encouragement throughout this experience. 
Thank you for pushing me to be my best as well as being my advocate and inspiring me to dream 
bigger than I had ever thought possible. Without you this entire piece of work would not have 
been possible. Next, I would like to thank the other members of the committee, Mrs. Lorena 
Cole, Dr. Ruth Stonestreet, Mrs. Katherine Walden, and Mrs. Chelsei Norris. Thank you for
taking time out of your busy lives to listen and support my endeavors. 
Lastly, I would like to thank my friends, my family, and my fiancé. Thank you for your 
constant words of encouragement and never-ending patience. Graduate school is not easy, and 
writing a thesis is not easy, but you all made it bearable. I love you all very much. 
 1
Chapter I
INTRODUCTION
Autism Spectrum disorders (ASD) are a group of neural developmental disorders which 
may be characterized by impairments in reciprocal social interaction and communication. ASD 
also presents with restricted repetitive behaviors, which affect 1 in 150 children (H.Yasuda, 
Yoshida, Y. Yasuda, & Tsutsui, 2013). Language and communication skill deficiencies are a 
critical dimension of the autism phenotype and are one of the most variable characteristics in 
individuals with ASD. Delayed language acquisition remains a hallmark to ASD for early to 
middle childhood. Language deficits associated with pragmatics, such as initiation and 
maintaining meaningful conversation, as well as differences in use of basic aspects of syntax, 
such as difficulties in the use of grammatical morphemes, remain key symptoms of ASD (Kim, 
Junker, & Lord, 2014).  These deficits are particularly apparent in low-functioning children with 
ASD (Tek, Mesite, Fein, Naigles, 2014).  
Results from research findings have contributed to the understanding that children with 
ASD exhibit substantial delays in language development relative to age-level, that there is 
considerable individual variation in language development within the autism spectrum, and that 
both expressive and receptive language are significantly hindered (Tek et al., 2014; Weismer,
Lord, & Esler, 2010).  One possible factor in the development of ASD, as well as the language 
deficits associated with the disorder, may be related to dietary deficiencies.  Yasuda et al., (2013) 
reported that many infants with ASD are suffering marginal to severe zinc deficiency, suggesting 
a relationship of infantile zinc deficiency and autism. 
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Zinc (Zn) is an essential mineral for growth, skin integrity, mental activity, wound 
healing, and immunocompetence and is considered a trace element (Schumacher, Domingo, & 
Corbella, 1994). Minerals and trace elements such as zinc play an essential role in the central 
nervous system. A lack or excess of these minerals are known to disrupt human body functions, 
including the immune system (Li, Wang, BjØrklund, Zhao, & Yin, 2014). Individuals deficient 
in zinc experience an increased susceptibility to various pathogens. Zinc is necessary in order to 
excrete toxic levels of minerals and pathogens. Due to the curial role of zinc in the immune 
system, this trace element has zinc dependent enzymes, which is necessary for nucleic acid 
metabolism (Russo, Bazin, & Bigega, 2012). Low plasma zinc may lead to copper toxicity, 
which could lead to liver dysfunction and neurological impairment in children (Faber, Zinn, Li,
& Kingston, 2009).  
Children with autism are known to have a suppressed immune system. Studies have also 
shown children with ASD have a decreased ability to excrete toxic metals, which leads to a 
higher body burden (Li et al., 2014). Copper (Cu) has many important roles in the human body. 
Copper is used for mechanisms of cell propagation and growth, and it also supports effective 
immune response through the promotion of inter-leukin-2 production using lymphocytic cells. 
Copper is a cofactor in many metalloenzymes including cytochrome c oxidase, cooper/zinc 
superoxide dismutase, and lysyl oxidase. Metalloenzymes contains a metal ion, typically held by 
a co-ordinate-covalent bond on the amino acid side chain, or they may bond to a prosthetic group 
(Li et al, 2014) Copper is considered a cofactor contributor, copper affects the human bodies 
response to oxidative stress, oxidative phosphorylation, and collagen biosynthesis. Increased 
copper concentrations may contribute to oxidative damage to lipids, nucleic acids, and proteins.  
Significant amounts of copper have been linked to several neurological diseases including 
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amyotrophic lateral sclerosis, Alzheimer’s disease, and Creuztzfeldt-Jacob disease (Faber et al., 
2009). 
Among the ASD community, the incidence rate of zinc deficiency is significantly 
increased compared to age-matched healthy control subjects. The occurrence of zinc deficiencies 
in ASD is particularly pronounced in younger children. Low levels of zinc found in the presence 
of copper excess contribute to an elevated cooper/zinc ratio, which was reported to correlate with 
the severity of symptoms associated with autism (Vela et al., 2015).
Children with ASD frequently have accompanying gastrointestinal (GI) and 
immunological symptoms, as well nonspecific neurological signs (Russo et al., 2012). Zinc is 
curial for the maintenance of the gastric mucosal integrity. Gastric mucosal integrity is essential 
for the blood flow and microcirculation of the gastric system (Vela, Stark, & Socha, 2015). Vela 
et al. (2015) performed a study on mice that experienced zinc deficiency accompanied with 
mucosal necrosis and ulceration as well as increased mucosal apoptosis, inflammation, edema, 
and structural alterations of villi. Villi are specialized for absorption in the small intestine as they 
consist of a thin wall, one cell thick, which enables a shorter path for diffusion. Villi have a large 
surface area in order to have efficient absorption of fatty acids and glycerol into the blood stream 
(Vela et al., 2015). Thus, when given a zinc supplementation, the mice showed beneficial effects 
on the mucosal integrity in many pathophysiological and inflammatory conditions of the small 
intestines (Vela et al., 2015). 
These findings, albeit specific to mice, indicate that zinc supplementation improves GI 
function.  Children with autism often report higher instances of GI problems, specifically the 
intestinal malabsorption of nutrients. In correlation to Vela et al. (2015), environmental triggers 
such as zinc deficiency have been linked to children with ASD. These children have been 
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characterized by behavioral neurodevelopmental disorders categorized by social deficits, 
language impairments, and repetitive behavior, which frequency occur with GI symptoms 
(Wasilewska & Klukowski, 2015). 
Given the positive findings from these studies, the specific aim of this study was to 
determine if zinc supplementation could be used as a type of intervention to assist with 
expressive language output in children associated with ASD. 
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Chapter II
REVIEW OF THE LITERATURE
Pervasive Developmental Disorders 
Pervasive developmental disorders are a group of neurological disorders that include
autism spectrum disorder (ASD) and Asperger’s syndrome (Faber et al., 2009). These disorders 
impair cognitive performance, reciprocal social interaction, and communication, and have 
unknown pathologies, but have been linked to genetic and environmental factors. Scientific 
breakthroughs have highlighted epigenetic alteration of gene expression by environmental 
influences as one possible key event in the pathogenesis of genetic diseases (Yasuda et al., 
2011). 
Weismer et al. (2010) observed characteristics in early language skills in a large 
population of toddlers with ASD. Their findings suggest that toddlers on the autism spectrum 
demonstrated significant delays based on age-level expectations in both comprehension and 
production. They found that children with developmental delay (DD), pervasive developmental 
disorder not otherwise specified (PDD-NOS), and autism exhibited substantial language delay 
compared to children of matching chronological age. Children with DD scored significantly 
higher on receptive and expressive language tasks related to children with ASD and PDD-NOS. 
Thus, children with PDD-NOS have been characterized as exhibited a significant language delay 
relative to typically developing children. Tek et al. (2013) conducted a longitudinal study of the 
trajectory as well as the variability of expressive language in young children with ASD. The 
authors analyzed morpho-syntactic measures, vocabulary, and sentence complexity using
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samples of spontaneous speech. The results of the study concluded that high-functioning children 
with ASD are similar to typically developing children in language development. However, low-
functioning children with ASD showed persistent language deficits over time, which the authors 
attributed to a global impairment in expressive language. Thus, while language deficits are 
typically associated with ASD, not all children with ASD will present with a language delay. 
Causes/Contributing Factors to Autism
Several factors may contribute to the development of autism. A number of research 
studies point to genetic predisposition, environmental triggers, and dietary deficiencies, e.g., 
inadequate intake of mineral and/or trace elements, as playing a role in ASD. Genetic 
predisposition to autism is evident from family and twin studies. Family studies have shown that 
autism is more frequent in families with autistic proband than the general population prevalence. 
Genome-wide linkage mapping studies cytogenetic abnormalities in autistic individuals, and 
candidate gene studies support the observation that autism is a multiple gene disorder with 
several interacting genes of moderate effect on different chromosomes (Bespalova & Buxbaum, 
2003).  Bespalova and Buxbaum (2003) studied several candidates’ genes and autism 
phenotypes. The results showed that an association with autism was reported for more than 15 
genes residing at different loci of human chromosomes. The authors reported that autism is likely 
caused by multiple interacting genes (Bespalova & Buxbaum, 2003). 
Environmental triggers have also been implicated in the development of ASD.  
Environmental toxins are associated with increases of oxidative stress, and can be further 
agitated with the combination of a suspected genetic predisposition such as ASD (Li et al., 
2014). Minerals and trace elements contributing to genetic and environmental triggers play an 
important role in the central nervous system. The lack of, or conversely, the excess of these 
 7
minerals and trace elements, is known to cause a variety of health implications such as 
developmental delay, malabsorption secondary to decreased functions of intestinal dependent 
enzymes, and may be a contributing factor in the etiology of ASD (Li et al., 2014). 
Role of Zinc
Zinc is one of the most prevalent ions in the brain and participates in the regulation of 
neurogenesis, neuronal migration, and differentiation, thereby shaping cognitive development 
and maintaining healthy brain functions (Vela et al., 2015). Zinc has a unique and extensive role
in the genetic processes. Since the discovery of zinc this element has been found to be essential 
for nutrients of living organisms and many diverse biochemical roles for it have been identified. 
These roles include enzyme function, nucleic acid metabolism, cell signaling, and apoptosis 
(Russo, 2011).  
The discovery of zinc has led scientists to believe that the element plays a crucial role in 
biological functions. Zinc has been identified in markers of deoxyribonucleic acid (DNA) 
damage, regulation of gamma-aminobutyric acid (GABA) and glutamate, and the absorption of 
intestinal zinc-dependent enzymes. Zinc is essential for several physiological processes, 
including growth and development, lipid metabolism, and brain and immune functions (Russo, 
2011). Zinc also plays important roles in nucleic acid/protein synthesis, cell replication, and 
tissue growth and repair (Yasuda et al., 2013). The lack of zinc, commonly known as “zinc 
deficiency,” has been associated with various pathological conditions, including impaired 
immunity, delayed wound healing, fetal growth delay, neural development disorders, and 
degenerative diseases (Yasuda et al., 2013). In regards to ASD, Yasuda et al. (2013) discovered 
that children with autism exhibited lower levels of zinc concentration, as measured from their 
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hair, when compared to normally developing children. Although only correlative, these findings 
suggest a relationship between zinc concentration and ASD.  
Individuals who suffer from zinc deficiency often demonstrate severely suppressed 
immune functions and emotional disturbances. Zinc provides an essential building block for 
metal responsive transcription factor-1 (MTF-1). MTF-1 enhances the transcription of 
metallothionein (MT) genes in response to heavy metal load as well as up and down regulations 
in high quantity amounts of genes and enzymes related to the elimination of heavy metals. MT is 
a cysteine-rich, low-molecular weight, intracellular protein with high attraction to metals and is 
the most common intracellular protein that binds to metal. The MT system is critical in heavy 
metal detoxification throughout the body (Faber et al., 2009). Zinc plays a role in the production 
of MT, thus decreases neurotoxicity. 
Copper is involved with the synthesis process of MT proteins. MT proteins have a higher 
attraction for copper and at times create a higher copper concentration. Copper is a catalyst for 
increasing physiological stress, a co-factor in neurological disease, and causes oxidative damage 
to lipids, nucleic acids, and proteins. Copper homeostasis needs to be controlled very closely, as 
copper becomes toxic in higher than normal concentrations. Uncontrolled copper absorption can 
become toxic to the central nervous system, especially during infancy due to incomplete liver 
functions. Changes in heavy metal concentrations such as zinc and copper have also been noted 
in neurological disorders, including Parkinson’s disease, Alzheimer’s disease, and Huntington’s 
disease (Faber et al., 2009).
In recent years, efforts have been made to establish normal limits and ratios pertaining 
to metals in various human media. Zinc and copper have antagonist results, with admiration to 
each other. A nearly 1:1 ratio of zinc and copper has been associated with more effective 
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immune responsiveness to infectious agents. The zinc to copper ratio has been associated as a 
method of regulating the functional state of the MT system, which, as previously noted, is crucial
in heavy metal detoxification. Low zinc/copper ratio has been linked to zinc deficiency and 
problems eliminating toxic heavy metals from tissues and blood through the MT system (Faber 
et al., 2009). In contrast, a higher copper to zinc ratio could be used as a biomarker for the 
diagnosis of autism (Russo et al., 2012). The study reports low zinc and high copper may control 
GABA receptors, ultimately changing transmitter awareness. Significant levels of copper are 
associated with high norepinephrine and high epinephrine levels within the body, which is 
further linked to perceive hyperactivity, typically correlated with symptoms of ASD (Russo et 
al., 2012). 
There is much support for the role of GABA in the etiology of ASD. GABA is 
considered a primary main excitatory and inhibitory neurotransmitter (Naaijen, Bralten, & 
Faraone, 2015). Alterations in the levels of GABA and its receptors indicate that the GABAergic 
system, which is responsible for synaptic inhibition, is involved in autism (Russo et al., 2012). 
Zinc has been associated in GABA and glutamate regulation, specifically through the anxiolytic 
activity reducing GABAergic inhibition. Copper contrastively has been found to be a potent 
inhibitor of GABA-evoked responses. Copper toxicity might result from GABA receptor 
blockage. Evidence strongly suggests that copper and zinc interact with each other in GABA 
receptor complexes and participate in altering synaptic transmission. Due to the copper’s high 
attraction to GABA-evoked response, zinc deficiency has been found to be associated with 
GABAergic impairment (Russo et al., 2012).
Early occurrence of zinc deficiency with a decline later in life, and the manifestation of 
some core features of ASD, such as impaired social behavior and language and communication 
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problems in prenatal zinc deficient mice, have recently put maternal zinc status in focus as a 
possible environmental factor in the etiology of ASD (Vela et al., 2015). Zinc deficiency may 
play a part during pregnancy and could negatively affect fetal development; this phenomenon 
has been observed in animal models and might be present in humans. Pregnant women that 
experience low zinc levels have shown correlations that affect the embryo’s intestinal epithelial 
development symptoms, which coincides with that of children associated with ASD (Vela et al., 
2015). Proper zinc levels are necessary for healthy gut development and both pre- and perinatal 
zinc deficiency could affect the neonate and cause downstream events that contribute to 
pathological processes. These processes may include but are not limited to inflammation, due to 
increased intestinal epithelium permeability and immune system abnormalities, including the 
generation of autoantibodies (Vela et al., 2015). 
Children with autism have exhibited higher instances of GI problems, specifically the 
intestinal malabsorption of nutrients. This syndrome may be referred to as “leaky gut syndrome” 
(Yasuda et al., 2013).  “Leaky gut syndrome” results in chronic inflammation, which influences 
the GI tract, due to empty spaces between cells that line the small intestine; this alteration could 
result in incompletely digested foods and other toxins entering the bloodstream. As a result, the 
immune system may respond by releasing antibodies against these substances. Inflammation of 
the GI can have a direct effect on the brain, causing behavioral and cognitive as well as 
psychiatric impairments. Appropriated together, GI abnormalities, immune system dysfunction, 
stress, and zinc deficiency are highly linked processes. The final result of these combined 
processes may be altered signaling to and within the developing brain, contributing to ASD 
(Vela et. al, 2015). 
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Zinc Supplementation Related to Treatment
During prenatal stages, females with insufficient zinc levels may take a zinc amino acid 
complex resulting in an increased zinc measurement during pregnancy, preserving the embryotic 
gut and brain development. Preserving the embryotic gut will decrease the chances of ASD-GI 
tract associated symptoms, decrease immune system activation, and decrease stress levels. Zinc 
supplementation has been suggested for infantile autistic participants with mineral disorders, 
such as zinc deficiency (Vela et al., 2015). 
Zinc supplementation has been shown to improve function in individuals with disorders 
other than autism. For example, Russo (2011) conducted a study in which individuals with 
diagnosed with anxiety were tested for zinc, copper, and anti-oxidant levels. Based on 
deficiencies, participants were prescribed an appropriate dose of antioxidants and supplements 
for a period of eight weeks. The results from the study found higher levels of copper and lower 
levels of zinc in participants with anxiety compared to control participants. After the period of 
supplementation, the Cu/Zn ratio improved as a result of an increase in zinc concentration levels.  
Ratings of anxiety also decreased in conjunction with the change in copper and zinc levels.  
Russo (2011) suggested that zinc supplementation may play a role in improving symptoms 
associated with anxiety 
Language Deficits 
While language is affected in many developmental conditions, profiles usually retain the 
normative balance of a receptive ability advantage over expressive skills. For many children with 
ASD, however, contrasting profiles are often seen, whereby raw receptive skills fail to show 
clear advantage over expressive skills (Hudry, Chandler, & Bedford, 2013). Thus, expressive 
language skills are often the focus of assessment and intervention. Language skills are often 
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examined in a play-based format. For example, Kim, Junker, and Lord (2014), conducted an 
investigation in which they studied the fidelity of measuring observations of spontaneous and 
expressive language (OSEL). OSEL was adapted as a 30-45 minute observational assessment, 
which focused on children’s expressive language use in standardized, but natural context. The 
assessment tool uses seven tasks to evaluate the child’s abilities. The Play Figure Assembly is an 
opportunity to interact within relatively easy and usually familiar play context, namely to 
construct different play figures through adding body parts and accessories to plastic figures. 
Clarifications, focused on eliciting requests for clarifications from a child based on the 
examiner’s comments and questions. During Telling a Picture Story the child was presented with 
four photographs which depicted a story or plot and then asked the child to describe the story to 
the examiner. Camping Trip/Picnic elicited spontaneous language productions within a loosely 
structured, motivating pretend-play activity. The next task consisted of the“Where is it?” Game;
this task intended to elicit the use of spatial prepositions. The Retell a Story: Where Are My 
French Fries? task gave the examiner a chance to observe the child’s semantic and narrative 
skills. Finally, the Picture Description gave the child the opportunity to describe objects, people, 
and events at multiple levels. The child is expected to use different word classes such as nouns, 
verbs, adjectives, and verb tenses such as future, present, pass, and forms while describing the 
vignette. The results of the study found that the OSEL was found to be a successful and 
measurable tool for evaluating children’s spontaneous expressive language. 
Results from an assessment tool such as the OSEL are useful in developing therapy goals, 
as the goals may be based on spontaneous productions. Lane, Lieberman-Betz, and Gast (2015) 
conducted an investigation to identify effective naturalistic language interventions of promoting 
spontaneous expressive language. The authors found that children with ASD benefit from 
 13
procedures in which adults embed opportunities to communicate during typical activities based 
on the child’s needs.  Four behavioral interventions to promote expressive language may be 
used: (a) verbal model of the target behavior, (b) mand-model procedure where an adult controls 
opportunities to use language, (c) time delay presentation of a stimulus and a specific delay for 
an independent response, and (d) incidental teaching. These strategies are used to target pivotal 
behaviors such as motivation responding to multiple cues, self-management, and initiating 
interactions. 
In order to maximize the impact of therapy on expressive language skills, it would be 
beneficial to ensure that an individual’s abilities to process and produce language are functioning 
to his/her maximum ability. As previously noted, zinc plays a vital role in mental function 
(Schumacher, Domingo, & Corbella, 1994). However, individuals with autism may exhibit 
marginal to severe deficiency, as well as exhibiting higher levels of copper (Yasuda et al., 2013;
Vela et al., 2015). This imbalance may contribute to autism and its associated symptoms (Vela et 
al., 2015). Prior research has documented improvement in other disorders, such as anxiety, 
following a period of zinc supplementation (Russo, 2011). It is possible that zinc 
supplementation may also improve function, specifically expressive language abilities, in 
individuals with autism. Hence, the purpose of this study was to investigate the use of zinc 
supplementation to improve homeostasis in the bodies of children associated with ASD whose
zinc to copper ratio would affect expressive language output. The results from this study will be 
used to answer the follow question:
Will zinc supplementation improve expressive language skills in a child with ASD?
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Based on this question, the following directional hypothesis was developed:
Zinc supplementation will improve expressive language skills in a child with ASD.
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Chapter III
METHODS
Participants
This study was approved by the Valdosta State University Institutional Review Board 
(see Appendix A). One participant was recruited from the Valdosta State Speech and Hearing 
Clinic. The participant had been previously diagnosed with ASD and was three years of age. The 
participant’s caregiver gave verbal consent to participate. The participant’s current level of 
communication included single word utterances and gesturing. 
Procedures
Initial speech and language evaluation. After the caretaker gave consent, the 
participant’s language skills were assessed by formal and informal means. Formal assessment 
included administration of the Preschool Language Scale -3 (PLS-3) (Zimmerman, Steiner, & 
Pond, 1992), which is an assessment tool used to assess receptive and expressive language skills 
in infants and young children. The PLS-3 also examines behaviors considered to be language 
precursors. The Goldman-Fristoe Test of Articulation- 2 (GFTA-II) (Goldman & Fristoe, 2000) 
was also administered during the child’s initial evaluation to assess the child’s articulation ability 
for both spontaneous and imitative sound production by responding to picture plates and verbal 
cues from the examiner. The primary purpose of the GFTA-II is to provide a means of assessing 
an individual’s articulation of consonant sounds. 
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Informal assessment of expressive language abilities was completed through direct and 
indirect tasks. The direct activity was a picture naming task during which the participant was 
asked to identify 10 images of verbs and 10 images depicting different emotions; the images 
were administered in random order. Correct and incorrect responses were recorded on a data 
sheet (see Appendix B). For the indirect task, the clinician tracked the number of word utterances 
produced during the picture naming task, structured therapy tasks, and pretend play, similar to 
some of the components described in the OSEL by Kim et al. (2014), during initial baseline 
sessions 
Articulation and expressive language goals were created based on the participant’s 
baseline testing. The articulation goal for the phoneme /p/ in isolation was created by means of 
sounds the child should have mastered by the age of three years. Language goals were developed 
based on the child’s performance on the PLS-3 and informal observations made during pretend 
play; the goals were created to increase spontaneous speech and sequence events, as well as 
increase the participant’s use of verbs and emotions for functional communication (Lane et al.,
2015).
After the clinician collected baseline data for two therapy sessions, the participant’s 
semester of therapy was separated into two phases. The first nine weeks of therapy sessions 
(Series A) was completed without zinc supplementation. The last seven weeks of therapy 
sessions (Series B) was completed with zinc supplementation. During the seven-week period of 
zinc supplementation, a week of data was not accounted for due to spring break. 
Measurement of zinc and copper levels. Prior to initiation of the Series B therapy 
sessions, urine specimens were collected from the participant from the first urination of the day 
to measure zinc and copper levels. The child provided two 10mL of urine into a sample cup; the 
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first was tested by means of an Osumex heavy metal (Zinc) test. The urine specimen was 
measured in parts per million (ppm) or milligrams per liter (mg/L); for the current study, the unit 
of measure was ppm. Per the directions for determining zinc levels by Osumex, reagent 1 was 
added to the urine sample and carefully blended. Following this procedure, reagents 2 and 
reagent 3 were stirred into the solution. Once all three reagents were added to the urine 
specimen, the sample was allowed to settle for five minutes. After exactly five minutes, a fourth 
reagent was added to the urine and mixed into the composite. Approximately one minute after 
the last reagent was added, a color strip provided by the manufacturer was compared to the result 
in the vial in order to evaluate zinc levels. 
The second 10 mL urine sample was analyzed using an Osumex heavy metal (Copper) 
test, measuring copper in ppmL. Per the directions for determining cooper levels, reagent 1 was 
added to the urine and mixed until completely dissolved. Next, a second reagent was stirred into 
the solution. Once the reagents were both completely dissolved, the mixture sat for five minutes. 
Finally, the color of the solution was again compared to the color of a strip provided within the 
test box.
At the completion of the Series B therapy sessions, zinc and copper levels were measured 
again, using the same procedure previously described. The participant was able to provide only a 
5 mL urine sample rather than a 10 mL sample.
Administration of zinc supplement. Once the zinc/copper ratios had been determined, 
the participant was administered a 50mg zinc supplement (Nature Made) crushed into applesauce 
for six weeks. The supplement was taken once daily with the first meal of the day. Over-the-
counter zinc supplements are commonly provided in 50mg doses. The caretaker was encouraged 
to monitor the participant for side effects associated with excessive zinc levels, e.g., nausea, 
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vomiting, respiratory difficulties, lethargy (Plum, Rink, & Haase, 2010). The caregiver checked 
with the primary physician before starting the participant on zinc.   
Collection of data during therapy. The participant’s clinician tracked expressive 
language goals on the provided data sheet and recorded a check if the child produced a correct 
response, and conversely, a cross if the child was incapable of generating the expected response.
The five expressive tasks were as follows:
(a) Goal 1- imitatively produce the phoneme /p/ in isolation by following visual 
cues presented by the clinician with 80% accuracy or above for three 
consecutive sessions
(b) Goal 2 - correctly using progressive verbs presented on picture cards in 
sentences when prompted by the clinician with 100% accuracy for three 
consecutive sessions
(c) Goal 3 - correctly use emotion words presented on picture cards in 
sentences when prompted by the clinician with 100% accuracy for three 
consecutive sessions
(d) Goal 4 - correctly sequence events with 80% accuracy or above for three 
consecutive sessions using a simple, three-step sequence provided by the 
clinician on picture cards
(e) Goal 5 - spontaneously producing three to four-word sentences, (e.g.,
describing objects and answering questions) responding to the clinician during 
play-based activities and structured therapy tasks with 100% accuracy for 
three consecutive sessions.  
 19
During play-based activities, the clinician elicited spontaneous speech production, production of 
the phoneme /p/ in isolation by following visual cues, and sequencing events, e.g., getting a doll 
dressed, making a sandwich with pretend kitchen food, and putting rings in size formation 
around a stick. In structured therapy tasks, the clinician used picture-naming cards clinician to 
elicit correct progressive verb usage and proper emotion usage. 
Analysis
Data were collected and analyzed separately from the therapy sessions for Series A and 
Series B. The average for each goal over the nine weeks of therapy in Series A and the six weeks 
of Series B was determined and compared to each other and to the baseline data. Results from 
Series B were also subtracted from those obtained during Series A to determine the change in 
function in conjunction with natural progression.  
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Chapter IV
RESULTS
The purpose of this research was to determine whether zinc supplementation would 
increase expressive language output in child with ASD. Two periods of therapy were conducted; 
the first for nine weeks and the second for six weeks. The first period, deemed Series A, was 
completed without zinc supplementation. The second period, Series B, was completed while the 
participant took a daily over-the-counter 50mg zinc tablet.
Summary of Expressive Language Function without Zinc Supplementation
To control for natural expected progression of the participant over the course of therapy, 
an exercise was undertaken to plot the expected results against actual outcomes using historical 
data gathered from nine prior therapy seasons once baseline goals had been established for the 
semester. Tables 1 through 5 shows the change in function from baseline and in therapy without 
zinc supplementation (Series A) and therapy with zinc supplementation (Series B) for each goal.
As noted in Table 1, the participant had a total increase of 250% improvement on Goal 1 
(imitative production of /p/ in isolation) from baseline through Series A and 31.41% 
improvement for Series B. The improvement was noted during both therapy periods, with the 
greatest amount of change occurring during the Series A sessions. As noted in Table 2, for Goal 
2 (correct use of progressive verbs shown on picture cards), the participant demonstrated no
change in both Series A and Series B sessions. Similar results were found for Goal 3, noted in 
Table 3 below (correct use emotion words presented on picture cards); the participant had 0% 
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increase in Series A. She did, however, exhibit a 14% decrease in Series B.  The results for Goal 
4 (correctly sequence events), shown in Table 4 showed a total increase of 300% from baseline 
during Series A but a 20% decrease in Series B. Similar to Goal 1, the greatest change occurred 
during Series A sessions. Lastly, for Goal 5 (production of 3-4 word sentences by responding to 
clinician prompting) and noted in Table 5, the participant exhibited a total increase of 90.91%
from baseline during Series A and a 36% increase in Series B. 
Heavy Metal Test Results
Before daily supplementation began, the participant’s zinc levels appeared to be at 0 
ppm using the Osumex heavy metals zinc test. The participants’ copper levels using the Osumex 
heavy metals copper test showed a level of 10 ppm. These results indicated the participant zinc 
to copper ratio 0ppm:10ppm, significantly lower levels of zinc in their body when compared to 
copper. Recommended normal limits a person should have a zinc to copper ratio equivalent of 
1:1.
After the six weeks of zinc supplementation, the participant’s zinc levels stood at 0.5 
ppm, while copper levels were at 0.0 ppm; these results indicated that the participants copper 
levels were significantly lower than zinc. Recommended normal limits indicate that an individual
should have a zinc to copper ratio equivalent of 1:1.
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Session Clinical Data % Change
Baseline 0%
no zinc 1 0%
no zinc 2 10%
no zinc 3 16% 60.00%
no zinc 4 33% 106.25%
no zinc 5 20% -39.39%
no zinc 6 35% 75.00%
no zinc 7 35% 0%
no zinc 8 20% -42.86%
no zinc 9 30% 50.00%
Maximum change from 
measurable data point 
(session 7 vs session 2) 250%
with zinc 1 46% 53.33%
with zinc 2 20% -56.52%
with zinc 3 30% 50.00%
with zinc 4 30% 0%
with zinc 5 46% 53.33%
with zinc 6 37% -19.57%
Maximum change with 
zinc supplementation
(no zinc 7 vs with zinc 1) 
31.43%
Table 1. Clinical data and percent change during the nine sessions of therapy without zinc 
supplementation and six sessions of therapy with zinc supplementation for Goal 1 (imitatively 
produce the phoneme /p/ in isolation when provided with visual cues).
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Session Clinical Data % Change
Baseline 100%
no zinc 1 100% 0%
no zinc 2 100% 0%
no zinc 3 90% -10.00%
no zinc 4 100% 11.11%
no zinc 5 100% 0%
no zinc 6 100% 0%
no zinc 7 100% 0%
no zinc 8 100% 0%
no zinc 9 100% 0%
Maximum change from 
baseline (session 9)
0%
with zinc 1 90% -10.00%
with zinc 2 95% 5.55%
with zinc 3 90% -5.26%
with zinc 4 95% 5.55%
with zinc 5 100% 5.26%
with zinc 6 100% 0%
Maximum change with 
zinc supplementation
(no zinc 9 vs with zinc 6) 
0%
Table 2. Clinical data and percent change during the nine sessions of therapy without zinc 
supplementation and six sessions of therapy with zinc supplementation for Goal 2 (correctly 
using progressive verbs presented on picture cards).
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Session Clinical Data % Change
Baseline 100%
no zinc 1 100% 0%
no zinc 2 100% 0%
no zinc 3 100% 0%
no zinc 4 100% 0%
no zinc 5 100% 0%
no zinc 6 100% 0%
no zinc 7 100% 0%
no zinc 8 100% 0%
no zinc 9 100% 0%
Maximum change from 
baseline (session 9)
0%
with zinc 1 100% 0%
with zinc 2 100% 0%
with zinc 3 80% -20.00%
with zinc 4 100% 25.00%
with zinc 5 93% -7.00%
with zinc 6 86% -7.53%
Maximum change with 
zinc supplementation
(no zinc 9 vs with zinc 6) 
-14.00%
Table 3. Clinical data and percent change during the nine sessions of therapy without zinc 
supplementation and six sessions of therapy with zinc supplementation for Goal 3 (correctly 
using emotion words presented on picture cards).
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Session Clinical Data % Change
Baseline 25%
no zinc 1 not addressed n/a
no zinc 2 not addressed n/a
no zinc 3 60% 140.00%
no zinc 4 100% 66.67%
no zinc 5 50% -50.00%
no zinc 6 100% 100%
no zinc 7 20% -80.00%
no zinc 8 80% 300.00%
no zinc 9 100% 25.00%
Maximum change from 
baseline (session 9)
300.00%
with zinc 1 100% 20.00%
with zinc 2 100% 0%
with zinc 3 80% -20.00%
with zinc 4 100% 25.00%
with zinc 5 100% 0%
with zinc 6 80% -20.00%
Maximum change with 
zinc supplementation
(no zinc 9 vs with zinc 6) 
-20.00%
Table 4. Clinical data and percent change during the nine sessions of therapy without zinc 
supplementation and six sessions of therapy with zinc supplementation for Goal 4 (correctly 
sequence events using a simple, three-step sequence provided on picture cards).
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Session Clinical Data % Change
Baseline 11%
no zinc 1 10% -9.09%
no zinc 2 15% 50.00%
no zinc 3 13% -13.33%
no zinc 4 20% 53.85%
no zinc 5 17% -15.00%
no zinc 6 20% -17.65%
no zinc 7 21% 5.00%
no zinc 8 18% -14.29%
no zinc 9 25% 38.89%
Maximum change from 
baseline (session 7)
90.91%
with zinc 1 21% 16.00%
with zinc 2 19% -9.52%
with zinc 3 24% 26.32%
with zinc 4 30% 25.00%
with zinc 5 34% 13.33%
with zinc 6 24% -29.41%
Maximum change with 
zinc supplementation
(no zinc 7 vs with zinc 5) 
36%
Table 5. Clinical data and percent change during the nine sessions of therapy without zinc 
supplementation and six sessions of therapy with zinc supplementation for Goal 5 
(spontaneously produce three- to four-word utterances during play-based and structured therapy 
tasks).
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Chapter V
DISCUSSION
The aim of the investigation was to examine the effect of zinc supplementation on 
expressive language function in a child with ASD. Specifically, it was hypothesized that zinc 
supplementation would increase expressive language abilities. The results of the study partially 
support the hypothesis of this study. The participant did demonstrate an improvement in two of 
the five goals (imitative production of /p/ in isolation and spontaneous production of 3-4 word 
utterances) during the period of zinc supplementation; however, a larger increase of growth was 
shown in Series A treatment without zinc supplementation.  It should be noted, however, that the 
participant also exhibited a slight decrease in two other goals (using emotion words correctly and 
sequencing events) during the period of zinc supplementation.
For both Goal 1 (imitative production of /p/ in isolation) and Goal 5 (spontaneous 
production of 3-4 word sentences), a considerable increase in performance was observed during 
Series A, with continued improvement, albeit on a much smaller scale, during Series B. Given 
that the increase observed during Series B falls within the range of change observed during 
Series A for both goals, these findings do not suggest that zinc supplementation had a marked 
effect on the participant’s skills in these areas. In addition, the substantial gains made by the 
participant during Series A indicate that she experienced significant growth in these tasks during
the initial phase of therapy. As the semester progressed, subsequent changes may have been 
minimal as she acquired these skills and/or reached a plateau in her learning abilities at this time.  
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Similarly, for Goal 4 (sequencing events), the participant demonstrated significant 
improvement in function during Series A, suggesting significant learning and growth during the 
initial phase of therapy.  She did exhibit a slight decline in function during Series B; however, 
this decrease was smaller than that observed during Series A, suggesting stabilization of this skill 
as she progressed.
For Goal 2 (progressive verb use) and Goal 3 (use of emotional words), no change in 
overall function occurred during Series A.  She maintained his performance level for Goal 2 but 
did demonstrate a slight decrease in proficiency for Goal 3. It is noteworthy, however, that the 
decline in performance during Series B for Goal 3 was still at a level high enough to meet the 
criteria established by her clinician for successful achievement of this skill. There are several 
possible reasons as to why she exhibited a decrease in performance during Series B for these 
goals. One possibility is that the zinc supplementation had a negative impact on her abilities in 
these areas, given that the declines were observed after zinc supplementation was initiated.  It is 
unclear why certain skills would be enhanced with zinc supplementation, e.g., phoneme imitation 
and spontaneous speech production, while others would be disrupted. Alternatively, the decrease 
in function for these two skills may be spurious in nature and/or related to extraneous factors, 
e.g., fatigue, participant engagement in therapy, etc. Her scores still succeeded the threshold of 
mastery for those skills.  Further investigation is warranted to determine if zinc supplementation 
affects language skills differentially. 
In sum, the effects of zinc supplementation on expressive language did not show 
conclusive evidence of an improvement on the effects of articulation, sequencing, progressive 
verbs, and emotion identification, and speech production Due to zinc supplementation being 
introduced halfway through the semester, it is inconclusive if the results would have been 
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different if zinc had been used at the beginning of the semester then towards the end of the study.
The participant’s ability to improve upon a task may show a higher percentage of learning at the 
start of a new concept then towards the middle of learning. As the participant gains mastery,
large improvements may not be readily seen. Whether the small declines in performance noted 
for two of the goals reflect natural variability in function that may occur over time or are a result 
of zinc supplementation are not clear.
The baseline testing indicated that the participant’s zinc/copper ratio was out of normal 
limits by having a 0ppm zinc level and having a 0.05ppm sensitivity to copper. Testing 
completed at the end of the semester, after six weeks of zinc supplementation, showed that the 
participant’s zinc levels were raised to .5ppm, and copper levels were decreased to 0ppm. Thus, 
the participant’s zinc levels showed a minor increase and copper levels decreased.
Limitations and Recommendations 
An investigation that incorporates toddlers associated with ASD and consent to take a 
daily supplement is a complicated topic. This research only included one participant; increasing 
the size of the sample would add to the current information and increase the generalizability of 
these results. Another limitation that was not accounted for was the child’s ability to provide a 
urine sample because he was not potty-trained. Although the participant’s caregiver gave consent 
for the study to proceed, there was a delay prior to starting the zinc supplementation due to the 
toilet training. As a result, the participant was only able to take the zinc supplementation for six
weeks. This contrasts with prior studies using zinc supplementation, which have utilized an eight 
week protocol. Subsequent studies should ensure that participants would be able to complete all 
testing requirements. Lastly, an extraneous variable was administration of the supplementation. 
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Since the investigator could not perform the regimen in person, one must assume that the child 
received the supplementation at the appropriate time and on a daily basis. 
Conclusions
Overall, the results do not clearly indicate that zinc supplementation in children with 
ASD could increase expressive language for length of utterances and expressing events. 
However, as noted above, unanticipated factors limited the duration of zinc supplementation and 
thus the potential impact on expressive language skills. These results did show a change in the 
zinc/copper ratio, which has been associated with severity of autism (Vela et al., 2015). This 
research highlights the need to investigate the levels of heavy metals present within children with 
ASD with subsequent dietary changes as needed, and the possible effects on language abilities. 
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